
Regeneron Pharmaceuticals: Analyst Reduces Price Target Amid Sales Concerns and Investor Lawsuit by Hagens Berman
Regeneron Pharmaceuticals: A Challenging Year Ahead Regeneron Pharmaceuticals, Inc. (REGN), a leading biotech company based in Tarrytown, New York, has been making headlines for less than desirable reasons lately. The company, which specializes in the development and commercialization of monoclonal antibody and other protein therapeutics for the treatment of serious medical conditions, has been facing…